Answers are grounded in this paper and cite their sources.
Objective To analyze the risk factors for central cervical lymph node metastasis (CLNM) in clinically node-negative (cN0) papillary thyroid microcarcinoma (PTMC) patients, thereby informing decisions regarding the extent of surgical dissection and the selection of candidates for active surveillance (AS). Additionally, to evaluate the incidence and determinants of lateral cervical lymph node metastasis (LLNM) in clinically node-positive (cN1) PTMC patients, facilitating postoperative risk stratification and follow-up management. Methods This study enrolled 519 patients who underwent surgery for pathologically confirmed PTMC at Beijing Sixth Hospital between 2023 and 2025. Clinicopathological data, including age, sex, maximal tumor diameter, tumor laterality, tumor location, number of foci, capsule invasion, extrathyroidal extension, coexistence of Hashimoto's thyroiditis (HT), and cervical lymph node status, were retrospectively collected. Univariate and multivariate logistic regression analyses were performed to identify independent risk factors for CLNM and LLNM. Results Among the 519 patients, cervical lymph node metastasis was observed in 232 cases (44.70%), while 287 (55.30%) had no nodal involvement. Specifically, isolated CLNM occurred in 201 patients (38.73%), concurrent CLNM and LLNM in 28 (5.39%), and skip lateral metastasis (without central compartment involvement) in 3 (0.58%). Male sex (p = 0.045), age <45 years (p < 0.001), and maximal tumor diameter ≥0.5 cm (p < 0.001) were identified as independent risk factors for CLNM. For LLNM, independent predictors included maximal tumor diameter ≥0.5 cm (p = 0.014) and the presence of concomitant CLNM (p = 0.001). Conclusion Male sex, age <45 years, and tumor size ≥0.5 cm are independent risk factors for CLNM in PTMC. For patients with these characteristics, proactive surgical intervention with prophylactic central lymph node dissection (CLND) is warranted. Conversely,patients without these risk factors could potentially be spared from prophylactic CLND or even surgery, and may be suitable for AS. Additionally, tumor diameter ≥0.5 cm and coexisting CLNM are independent predictors of LLNM; patients with these features should be categorized as high-risk for recurrence and receive intensified postoperative surveillance.
No takes yet. Share an insight, caveat, or question.
Xuemei Wu (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: